Credit Suisse’s MaxCyte MXCT Stock Holding History

Credit Suisse’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$347K	Buy	82,801 +1,867	+2%	+$8.76K	﹤0.01%	2782
2023 Q4	$380K	Buy	80,934 +11,573	+17%	+$45.1K	﹤0.01%	2846
2023 Q3	$216K	Sell	69,361 -4,674	-6%	-$18.8K	﹤0.01%	3015
2023 Q2	$340K	Buy	74,035 +17,456	+31%	+$80.2K	﹤0.01%	2963
2023 Q1	$280K	Buy	56,579 +7,003	+14%	+$34.5K	﹤0.01%	3016
2022 Q4	$271K	Buy	49,576 +5,857	+13%	+$35.9K	﹤0.01%	3084
2022 Q3	$284K	Buy	43,719 +503	+1%	+$2.81K	﹤0.01%	3107
2022 Q2	$204K	Sell	43,216 -2,327	-5%	-$11.5K	﹤0.01%	3317
2022 Q1	$319K	Buy	45,543 +373	+0.8%	+$2.55K	﹤0.01%	3195
2021 Q4	$460K	Buy	+45,170	New	+$485K	﹤0.01%	3871

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse's MXCT Position: Q1 2024 in Review

Credit Suisse increased its MaxCyte (MXCT) stake by 2.3% in Q1 2024, buying an estimated $8.76K and bringing the position to 82,801 shares worth $347K. The position accounts for ﹤0.01% of the portfolio, ranked #2782.

Credit Suisse first reported a position in MXCT in Q4 2021 and has held it in 10 quarters since. The position peaked at $460K in Q4 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q1 2024.

Credit Suisse held 82,801 shares of MaxCyte worth $347K as of Q1 2024.
Credit Suisse bought 1,867 MaxCyte shares in Q1 2024, an estimated $8.76K.
MaxCyte made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2782 holding.
Credit Suisse first reported a position in MaxCyte in Q4 2021 and has held it in 10 quarters since.
Credit Suisse's MaxCyte position peaked at $460K in Q4 2021.
123 funds tracked by Wall St. Rank held MaxCyte as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.